drugset
drugset / Trial / NCT06982651

A Study on the Safety, Pharmacokinetics, and Food Effects of MI078 Capsules

NCT06982651 ↗

Phase 1 Completed 98 enrolled Nanjing Minova Pharmaceutical Co., Ltd.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study was divided into three studies, namely, a single administration study, a food impact study, and a multiple administration study.

Timeline

Start
2023-09-09
Primary completion
2024-03-18
Completion
2024-03-18

Drugs

EvaluationDrugModalityDoseRoute
Subject MI078 Unknown 25 mg Oral
Subject MI078 Unknown 50 mg Oral
Subject MI078 Unknown 100 mg Oral
Subject MI078 Unknown 200 mg Oral
Subject MI078 Unknown 400 mg Oral
Subject MI078 Unknown 600 mg Oral
Subject MI078 Unknown 800 mg Oral
Subject MI078 Unknown 1000 mg Oral

Indications

postpartum depression